Dr. Stephen C. Medlin
Overview
Dr. Stephen Medlin is a specialty care physician board certified in hematology, internal medicine and medical oncology. He joined Inova in 2023 and has been practicing since 2001. Prior to joining Inova, Dr. Medlin worked as Director of the Hematologic Malignancy and Stem Cell Transplant Program; Director of Quality and FACT, Hematologic Malignancies and Transplant; and Medical Director of Aurora Cellular Processing/CLIA Director at Aurora Health Systems. He also worked as a Clinical Adjunct Full Professor of Medicine at the University of Wisconsin School of Medicine and Public Health in Madison, WI. He currently serves as a Professor of Medicine, Clinical Instructor Track, at the University of Virginia. Dr. Medlin’s clinical areas of interest include multiple myeloma, lymphoma, acute leukemia, and T-cell lymphoma. He believes in a multidisciplinary approach to patient care. He strives to deliver the highest quality of medical care and to integrate it within a system of care delivery that utilizes team members who address the social, psychological and financial aspects of a patient’s care needs. Under Dr. Medlin’s care, patients are educated about their primary disease and the care options that may be available. He discusses any questions about the diagnosis or care choices that the patient and family may have, then touches on elements of important care goals and personal goals for the patient or family. He strives to make sure that every patient has their questions answered, so he can work with his team to help them meet their goals and be successful through additional social and financial support.
Dr. Medlin is highly rated in 17 conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
His clinical research consists of co-authoring 13 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Awards
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- POS
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8081 Innovation Park Dr, Level 4 - Skyline Clinic, Fairfax, VA 22031
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Office
Sharon Savage is a Hematologist and an Oncologist in Bethesda, Maryland. Dr. Savage is highly rated in 19 conditions, according to our data. Her top areas of expertise are Dyskeratosis Congenita, Aplastic Anemia, Aase Syndrome, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).
Office
Blanche Alter is a Hematologist and an Oncologist in Rockville, Maryland. Dr. Alter is highly rated in 13 conditions, according to our data. Her top areas of expertise are Aase Syndrome, Dyskeratosis Congenita, Aplastic Anemia, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).
Office
Taofeek Owonikoko is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Frequently Asked Questions about Dr. Stephen C. Medlin
How do I make an appointment with Dr. Stephen C. Medlin?
You can book an appointment with Dr. Stephen C. Medlin by calling their office at 571-472-1390. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Stephen C. Medlin a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stephen C. Medlin is classified as an Distinguished expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Stephen C. Medlin specialize in?
While Dr. Stephen C. Medlin is a Hematology, they have specific expertise in Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Stephen C. Medlin participate in research or clinical trials?
Yes. Dr. Stephen C. Medlin has published 13 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Dr. Stephen C. Medlin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Stephen C. Medlin accept my insurance?
Dr. Stephen C. Medlin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 571-472-1390 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Medlin isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Medlin isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow AspirationDr. Medlin isAdvanced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Medlin isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Medlin isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Medlin isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Promyelocytic LeukemiaDr. Medlin isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Medlin isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Medlin isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Aplastic AnemiaDr. Medlin isExperienced. Learn about Aplastic Anemia.
- Ataxia-Pancytopenia SyndromeDr. Medlin isExperienced. Learn about Ataxia-Pancytopenia Syndrome.